Results 91 to 100 of about 23,440 (199)

Belimumab induces early and sustained resolution of lupus thrombocytopenia. [PDF]

Lupus Sci Med
Leuchten N, Parodis I, Brinks R, Aringer M.   +3 more
europepmc   +1 more source

Prospective Assessment of Short-Term Response and Acute Toxicity With Accelerated Fractionation Radiotherapy Versus Concurrent Chemoradiotherapy in Locally Advanced Cervical Cancer. [PDF]

Cureus
Das P, Deepthi GV, Chevireddy P, Subramanian BV, Bonala SR.   +4 more
europepmc   +1 more source

Personalized thiopurine dosing based on TPMT genotyping reduces leucopenia occurrence and results in cost-savings in IBD patients. Results from a randomized trial in the Netherlands

, 2014
Background: More than 20% of inflammatory bowel diseases (IBD) patients discontinue thiopurine therapy due to severe adverse drug reactions among which leucopenia is one of the most serious. Thiopurine S-methyltransferase (TPMT) pharmacogenetics has been
Wong, D., Klungel, O., Van Marrewijk, C., Verbeek, A., Guchelaar, H.-J., Derijks, L., Scheffer, H., Sub Pharmacotherapy, Theoretical, Coenen, M., Vermeulen, S., Hooymans, P., Pharmacoepidemiology and Clinical Pharmacology, Franke, B., De Jong, D.   +13 more
core  

Biochemical Profile at Residential Admission in Anorexia Nervosa: Comparable Findings Across Restricting and Binge-Purge Subtypes. [PDF]

Nutrients
Monaco F, Vignapiano A, Landi S, Panarello E, Bonifacio R, Falchetta D, Marenna A, Di Rosa D, Collura A, Mainardi A, Steardo L, Sosto G, Corrivetti G.   +12 more
europepmc   +1 more source

Efficacy of belimumab in patients with SLE and haematological manifestations: retrospective analysis from the BeRLiSS 2.0 cohort. [PDF]

Lupus Sci Med
Hulej G, Arru F, Bianchi B, Bortoluzzi A, Brussino L, Castrignanò P, Cauli A, Cavagna L, Chessa E, Chiara E, De Angelis R, De Marchi G, Depascale R, Di Carlo M, Emmi G, Galvagni I, Gasparotto M, Gatto M, Gerli R, Govoni M, Lo Gullo A, Nano A, Negrini S, Noviello S, Orsolini G, Pazzola G, Piga M, Quartuccio L, Rossini M, Salvarani C, Silvagni E, Silvestri E, Tamussin M, Tizian M, Tomietto P, Urban ML, Vacca A, Vesentini F, Bracalenti M, Ramonda R, Doria A, Iaccarino L, Zen M.   +42 more
europepmc   +1 more source

Plaquetopenia, leucopenia y aumento del hematocrito como predictores de dengue en febriles

Introducción: El dengue es una enfermedad viral transmitida por mosquitos, el 2023 se incrementó en Chimbote, impulsando la necesidad de validar la plaquetopenia, leucopenia y aumento del hematocrito como predictores de dengue en el diagnóstico ...
Marin Gómez, Tiana Solanch, Albitres Cerna, Akami Mayumi   +1 more
core  

Nonchemotherapy drug-induced cytopenias: A cost-of-illness study using the microcosting methodology based on real-world data

Aims: Our study aimed to determine the healthcare utilization and costs of nonchemotherapy drug-induced cytopenias and analyse the main drivers of costs.
Petrović, Nemanja, Čanak-Baltić, Nataša, Lakić, Dragana, Janković, Slobodan M., Marinković, Valentina, Stević, Ivana   +5 more
core   +1 more source

Granular Leucopenia [PDF]

Proceedings of the Royal Society of Medicine, 1944
openaire   +1 more source

Littoral Cell Angioma of the Spleen Presenting With Hypersplenism: A Case Report. [PDF]

Cureus
Tohfa SA, Riyad M, Faisel M, Arefin M, Jamila M.   +4 more
europepmc   +1 more source

Can disease activity and treatment responses be captured by a core set of domains in SLE clinical trials? An analysis of phase III belimumab trial data. [PDF]

Lupus Sci Med
Lin A, Kandane-Rathnayake R, Morand EF, Connelly K.   +3 more
europepmc   +1 more source